Use of Collateral Sensitivity Networks to Design Drug Cycling Protocols That Avoid Resistance Development

Antimicrobial stewardship programs (ASPs)

(2013) Cheston B. Cunha et al.   Virulence

Outwitting Evolution: Fighting Drug-Resistant TB, Malaria, and HIV

(2012) Daniel E. Goldberg et al.   CELL

Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks

(2012) Michael J. Lee et al.   CELL

Selection of resistance at lethal and non-lethal antibiotic concentrations

(2012) Diarmaid Hughes et al.   CURRENT OPINION IN MICROBIOLOGY

Collateral sensitivity as a strategy against cancer multidrug resistance

(2012) Kristen M. Pluchino et al.   DRUG RESISTANCE UPDATES

A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit

(2012) Shiva Sarraf-Yazdi et al.   JOURNAL OF SURGICAL RESEARCH

Scaling up interventions to achieve global tuberculosis control: progress and new developments

(2012) Mario Raviglione et al.   LANCET

Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?

(2012) P. Borst   Open Biology

The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors

(2012) Keith P. Romano et al.   PLoS Pathogens

Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment

(2011) Michael A. Pfaller   AMERICAN JOURNAL OF MEDICINE

Impaired Fitness and Transmission of Macrolide-Resistant Campylobacter jejuni in Its Natural Host

(2011) Taradon Luangtongkum et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Challenges of Antibacterial Discovery

(2011) L. L. Silver   CLINICAL MICROBIOLOGY REVIEWS

Combination therapies for combating antimicrobial resistance

(2011) Michael A Fischbach   CURRENT OPINION IN MICROBIOLOGY

Antibiotic heterogeneity: from concept to practice

(2010) A. M. Bal et al.   Annals of the New York Academy of Sciences

Antibiotic Sensitivity Profiles Determined with an Escherichia coli Gene Knockout Collection: Generating an Antibiotic Bar Code

(2010) A. Liu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis

(2010) Benedetta Allegranzi et al.   LANCET

Hospital-Acquired Infections Due to Gram-Negative Bacteria

(2010) Anton Y. Peleg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections

(2010) Alexandro Rodríguez-Rojas et al.   PLoS One

Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use

(2009) M. Sundqvist et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antibiotics for Emerging Pathogens

(2009) M. A. Fischbach et al.   SCIENCE

Interplay in the Selection of Fluoroquinolone Resistance and Bacterial Fitness

(2009) Linda L. Marcusson et al.   PLoS Pathogens

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Determination of Antibiotic Hypersensitivity among 4,000 Single-Gene-Knockout Mutants of Escherichia coli

(2008) C. Tamae et al.   JOURNAL OF BACTERIOLOGY